Table 5.
Normalized values of Δ urinary 11β-PGF2α with exercise challenge
| Category | Group | Week 0 | Week 2 | Week 4 | Week 8 |
p- valuea |
| % change in 11β-PGF2α excretion. (All subjects) | Yoga (n = 29) |
17.6 ± 18.6 | 19.7 ± 24.7 | 14.7 ± 16.5 | 16.8 ± 19.7 | 0.49 |
| Control (n = 28) | 16.6 ± 21.0 | 18.6 ± 22.0 | 16.3 ± 22.3 | 20.7 ± 23.5 | 0.84 | |
| ES subjects (mean ± SD) |
Yoga (n = 13) |
18.3 ± 22.2 | 20.4 ± 29.5 | 13.8 ± 16.8 | 12.3 ± 16.9 | 0.63 |
| Control (n = 9) |
15.5 ± 21.2 | 13.3 ± 18.1 | 28.5 ± 16.3* | 18.9 ± 8.2 | 0.11 | |
| ER subjects (mean ± SD) |
Yoga (n = 16) |
17.1 ± 15.9 | 19.0 ± 21.0 | 15.4 ± 16.8 | 20.4 ± 21.5 | 0.79 |
| Control (n = 19) |
17.0 ± 21.5 | 21.1 ± 23.6 | 10.6 ± 22.8 | 21.6 ± 28.2 | 0.08 | |
All values (normalized) are expressed as % change in 11β prostaglandin F2α excretion with exercise challenge (mean ± SD). ES – exercise sensitive; ER – exercise resistant subjects.
aP-value was based on Friedman test in each group separately from % change in 11β-PGF2α with exercise.
*p < .05 based on Mann-Whitney U test at 4 wk between two groups.